# Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme

> **NCT00331526** · PHASE2 · COMPLETED · sponsor: **Hoag Memorial Hospital Presbyterian** · enrollment: 83 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** therapeutic autologous lymphocytes
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00331526
- **Lead sponsor:** Hoag Memorial Hospital Presbyterian
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02
- **Primary completion:** 2008-12
- **Final completion:** 2012-04
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2013-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331526, "Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00331526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*